Why Is BioAge Labs Stock Sinking Friday? - Neumora Therapeutics (NASDAQ:NMRA), Bioage Labs (NASDAQ:BIOA)

BioAge Labs stock plummeted as failed Phase 3 ZEUS trial data from Novo Nordisk sparked broad concerns for NLRP3-targeting therapies.

Raccontata dabenzinga.com